Global Recombinant Coagulation Factors Market Growth (Status and Outlook) 2025-2031

December 2025 | 89 pages | ID: G531E2CFF17DEN
LP Information

Abstracts

According to this study, the global Recombinant Coagulation Factors market size will reach US$ million by 2031.

Recombinant coagulation factors are plasma derived counterparts used to treat infection from viruses such as hepatitis C and the human immunodeficiency virus. In addition, recombinant coagulation factors have low risk for transmission of infectious agents.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

LPI (LP Information)' newest research report, the “Recombinant Coagulation Factors Industry Forecast” looks at past sales and reviews total world Recombinant Coagulation Factors sales in 2024, providing a comprehensive analysis by region and market sector of projected Recombinant Coagulation Factors sales for 2025 through 2031. With Recombinant Coagulation Factors sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Recombinant Coagulation Factors industry.

This Insight Report provides a comprehensive analysis of the global Recombinant Coagulation Factors landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Recombinant Coagulation Factors portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Recombinant Coagulation Factors market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Recombinant Coagulation Factors and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Recombinant Coagulation Factors.

This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Coagulation Factors market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Recombinant Factor VIII
• Recombinant Factor IX
• Von Willebrand Factor

Segmentation by Application:

• Hospitals
• Clinics
• Research Organizations

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Baxter International Inc.
• Bayer AG
• Biogen Idec
• CSL Ltd.
• Grifols International SA
• Kedrion S.P.A.
• Novo Nordisk A/S
• Octapharma AG
• Pfizer Inc.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Recombinant Coagulation Factors Market Size (2020-2031)
  2.1.2 Recombinant Coagulation Factors Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Recombinant Coagulation Factors by Country/Region (2020, 2024 & 2031)
2.2 Recombinant Coagulation Factors Segment by Type
  2.2.1 Recombinant Factor VIII
  2.2.2 Recombinant Factor IX
  2.2.3 Von Willebrand Factor
2.3 Recombinant Coagulation Factors Market Size by Type
  2.3.1 Recombinant Coagulation Factors Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Recombinant Coagulation Factors Market Size Market Share by Type (2020-2025)
2.4 Recombinant Coagulation Factors Segment by Application
  2.4.1 Hospitals
  2.4.2 Clinics
  2.4.3 Research Organizations
2.5 Recombinant Coagulation Factors Market Size by Application
  2.5.1 Recombinant Coagulation Factors Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Recombinant Coagulation Factors Market Size Market Share by Application (2020-2025)

3 RECOMBINANT COAGULATION FACTORS MARKET SIZE BY PLAYER

3.1 Recombinant Coagulation Factors Market Size Market Share by Player
  3.1.1 Global Recombinant Coagulation Factors Revenue by Player (2020-2025)
  3.1.2 Global Recombinant Coagulation Factors Revenue Market Share by Player (2020-2025)
3.2 Global Recombinant Coagulation Factors Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 RECOMBINANT COAGULATION FACTORS BY REGION

4.1 Recombinant Coagulation Factors Market Size by Region (2020-2025)
4.2 Global Recombinant Coagulation Factors Annual Revenue by Country/Region (2020-2025)
4.3 Americas Recombinant Coagulation Factors Market Size Growth (2020-2025)
4.4 APAC Recombinant Coagulation Factors Market Size Growth (2020-2025)
4.5 Europe Recombinant Coagulation Factors Market Size Growth (2020-2025)
4.6 Middle East & Africa Recombinant Coagulation Factors Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Recombinant Coagulation Factors Market Size by Country (2020-2025)
5.2 Americas Recombinant Coagulation Factors Market Size by Type (2020-2025)
5.3 Americas Recombinant Coagulation Factors Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Recombinant Coagulation Factors Market Size by Region (2020-2025)
6.2 APAC Recombinant Coagulation Factors Market Size by Type (2020-2025)
6.3 APAC Recombinant Coagulation Factors Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Recombinant Coagulation Factors Market Size by Country (2020-2025)
7.2 Europe Recombinant Coagulation Factors Market Size by Type (2020-2025)
7.3 Europe Recombinant Coagulation Factors Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Recombinant Coagulation Factors by Region (2020-2025)
8.2 Middle East & Africa Recombinant Coagulation Factors Market Size by Type (2020-2025)
8.3 Middle East & Africa Recombinant Coagulation Factors Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL RECOMBINANT COAGULATION FACTORS MARKET FORECAST

10.1 Global Recombinant Coagulation Factors Forecast by Region (2026-2031)
  10.1.1 Global Recombinant Coagulation Factors Forecast by Region (2026-2031)
  10.1.2 Americas Recombinant Coagulation Factors Forecast
  10.1.3 APAC Recombinant Coagulation Factors Forecast
  10.1.4 Europe Recombinant Coagulation Factors Forecast
  10.1.5 Middle East & Africa Recombinant Coagulation Factors Forecast
10.2 Americas Recombinant Coagulation Factors Forecast by Country (2026-2031)
  10.2.1 United States Market Recombinant Coagulation Factors Forecast
  10.2.2 Canada Market Recombinant Coagulation Factors Forecast
  10.2.3 Mexico Market Recombinant Coagulation Factors Forecast
  10.2.4 Brazil Market Recombinant Coagulation Factors Forecast
10.3 APAC Recombinant Coagulation Factors Forecast by Region (2026-2031)
  10.3.1 China Recombinant Coagulation Factors Market Forecast
  10.3.2 Japan Market Recombinant Coagulation Factors Forecast
  10.3.3 Korea Market Recombinant Coagulation Factors Forecast
  10.3.4 Southeast Asia Market Recombinant Coagulation Factors Forecast
  10.3.5 India Market Recombinant Coagulation Factors Forecast
  10.3.6 Australia Market Recombinant Coagulation Factors Forecast
10.4 Europe Recombinant Coagulation Factors Forecast by Country (2026-2031)
  10.4.1 Germany Market Recombinant Coagulation Factors Forecast
  10.4.2 France Market Recombinant Coagulation Factors Forecast
  10.4.3 UK Market Recombinant Coagulation Factors Forecast
  10.4.4 Italy Market Recombinant Coagulation Factors Forecast
  10.4.5 Russia Market Recombinant Coagulation Factors Forecast
10.5 Middle East & Africa Recombinant Coagulation Factors Forecast by Region (2026-2031)
  10.5.1 Egypt Market Recombinant Coagulation Factors Forecast
  10.5.2 South Africa Market Recombinant Coagulation Factors Forecast
  10.5.3 Israel Market Recombinant Coagulation Factors Forecast
  10.5.4 Turkey Market Recombinant Coagulation Factors Forecast
10.6 Global Recombinant Coagulation Factors Forecast by Type (2026-2031)
10.7 Global Recombinant Coagulation Factors Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Recombinant Coagulation Factors Forecast

11 KEY PLAYERS ANALYSIS

11.1 Baxter International Inc.
  11.1.1 Baxter International Inc. Company Information
  11.1.2 Baxter International Inc. Recombinant Coagulation Factors Product Offered
  11.1.3 Baxter International Inc. Recombinant Coagulation Factors Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Baxter International Inc. Main Business Overview
  11.1.5 Baxter International Inc. Latest Developments
11.2 Bayer AG
  11.2.1 Bayer AG Company Information
  11.2.2 Bayer AG Recombinant Coagulation Factors Product Offered
  11.2.3 Bayer AG Recombinant Coagulation Factors Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Bayer AG Main Business Overview
  11.2.5 Bayer AG Latest Developments
11.3 Biogen Idec
  11.3.1 Biogen Idec Company Information
  11.3.2 Biogen Idec Recombinant Coagulation Factors Product Offered
  11.3.3 Biogen Idec Recombinant Coagulation Factors Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Biogen Idec Main Business Overview
  11.3.5 Biogen Idec Latest Developments
11.4 CSL Ltd.
  11.4.1 CSL Ltd. Company Information
  11.4.2 CSL Ltd. Recombinant Coagulation Factors Product Offered
  11.4.3 CSL Ltd. Recombinant Coagulation Factors Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 CSL Ltd. Main Business Overview
  11.4.5 CSL Ltd. Latest Developments
11.5 Grifols International SA
  11.5.1 Grifols International SA Company Information
  11.5.2 Grifols International SA Recombinant Coagulation Factors Product Offered
  11.5.3 Grifols International SA Recombinant Coagulation Factors Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Grifols International SA Main Business Overview
  11.5.5 Grifols International SA Latest Developments
11.6 Kedrion S.P.A.
  11.6.1 Kedrion S.P.A. Company Information
  11.6.2 Kedrion S.P.A. Recombinant Coagulation Factors Product Offered
  11.6.3 Kedrion S.P.A. Recombinant Coagulation Factors Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Kedrion S.P.A. Main Business Overview
  11.6.5 Kedrion S.P.A. Latest Developments
11.7 Novo Nordisk A/S
  11.7.1 Novo Nordisk A/S Company Information
  11.7.2 Novo Nordisk A/S Recombinant Coagulation Factors Product Offered
  11.7.3 Novo Nordisk A/S Recombinant Coagulation Factors Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Novo Nordisk A/S Main Business Overview
  11.7.5 Novo Nordisk A/S Latest Developments
11.8 Octapharma AG
  11.8.1 Octapharma AG Company Information
  11.8.2 Octapharma AG Recombinant Coagulation Factors Product Offered
  11.8.3 Octapharma AG Recombinant Coagulation Factors Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Octapharma AG Main Business Overview
  11.8.5 Octapharma AG Latest Developments
11.9 Pfizer Inc.
  11.9.1 Pfizer Inc. Company Information
  11.9.2 Pfizer Inc. Recombinant Coagulation Factors Product Offered
  11.9.3 Pfizer Inc. Recombinant Coagulation Factors Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Pfizer Inc. Main Business Overview
  11.9.5 Pfizer Inc. Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Recombinant Coagulation Factors Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Recombinant Coagulation Factors Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Recombinant Factor VIII
Table 4. Major Players of Recombinant Factor IX
Table 5. Major Players of Von Willebrand Factor
Table 6. Recombinant Coagulation Factors Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Recombinant Coagulation Factors Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Recombinant Coagulation Factors Market Size Market Share by Type (2020-2025)
Table 9. Recombinant Coagulation Factors Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Recombinant Coagulation Factors Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Recombinant Coagulation Factors Market Size Market Share by Application (2020-2025)
Table 12. Global Recombinant Coagulation Factors Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Recombinant Coagulation Factors Revenue Market Share by Player (2020-2025)
Table 14. Recombinant Coagulation Factors Key Players Head office and Products Offered
Table 15. Recombinant Coagulation Factors Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Recombinant Coagulation Factors Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Recombinant Coagulation Factors Market Size Market Share by Region (2020-2025)
Table 20. Global Recombinant Coagulation Factors Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Recombinant Coagulation Factors Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Recombinant Coagulation Factors Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Recombinant Coagulation Factors Market Size Market Share by Country (2020-2025)
Table 24. Americas Recombinant Coagulation Factors Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Recombinant Coagulation Factors Market Size Market Share by Type (2020-2025)
Table 26. Americas Recombinant Coagulation Factors Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Recombinant Coagulation Factors Market Size Market Share by Application (2020-2025)
Table 28. APAC Recombinant Coagulation Factors Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Recombinant Coagulation Factors Market Size Market Share by Region (2020-2025)
Table 30. APAC Recombinant Coagulation Factors Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Recombinant Coagulation Factors Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Recombinant Coagulation Factors Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Recombinant Coagulation Factors Market Size Market Share by Country (2020-2025)
Table 34. Europe Recombinant Coagulation Factors Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Recombinant Coagulation Factors Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Recombinant Coagulation Factors Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Recombinant Coagulation Factors Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Recombinant Coagulation Factors Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Recombinant Coagulation Factors
Table 40. Key Market Challenges & Risks of Recombinant Coagulation Factors
Table 41. Key Industry Trends of Recombinant Coagulation Factors
Table 42. Global Recombinant Coagulation Factors Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Recombinant Coagulation Factors Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Recombinant Coagulation Factors Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Recombinant Coagulation Factors Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Baxter International Inc. Details, Company Type, Recombinant Coagulation Factors Area Served and Its Competitors
Table 47. Baxter International Inc. Recombinant Coagulation Factors Product Offered
Table 48. Baxter International Inc. Recombinant Coagulation Factors Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Baxter International Inc. Main Business
Table 50. Baxter International Inc. Latest Developments
Table 51. Bayer AG Details, Company Type, Recombinant Coagulation Factors Area Served and Its Competitors
Table 52. Bayer AG Recombinant Coagulation Factors Product Offered
Table 53. Bayer AG Recombinant Coagulation Factors Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Bayer AG Main Business
Table 55. Bayer AG Latest Developments
Table 56. Biogen Idec Details, Company Type, Recombinant Coagulation Factors Area Served and Its Competitors
Table 57. Biogen Idec Recombinant Coagulation Factors Product Offered
Table 58. Biogen Idec Recombinant Coagulation Factors Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Biogen Idec Main Business
Table 60. Biogen Idec Latest Developments
Table 61. CSL Ltd. Details, Company Type, Recombinant Coagulation Factors Area Served and Its Competitors
Table 62. CSL Ltd. Recombinant Coagulation Factors Product Offered
Table 63. CSL Ltd. Recombinant Coagulation Factors Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. CSL Ltd. Main Business
Table 65. CSL Ltd. Latest Developments
Table 66. Grifols International SA Details, Company Type, Recombinant Coagulation Factors Area Served and Its Competitors
Table 67. Grifols International SA Recombinant Coagulation Factors Product Offered
Table 68. Grifols International SA Recombinant Coagulation Factors Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Grifols International SA Main Business
Table 70. Grifols International SA Latest Developments
Table 71. Kedrion S.P.A. Details, Company Type, Recombinant Coagulation Factors Area Served and Its Competitors
Table 72. Kedrion S.P.A. Recombinant Coagulation Factors Product Offered
Table 73. Kedrion S.P.A. Recombinant Coagulation Factors Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Kedrion S.P.A. Main Business
Table 75. Kedrion S.P.A. Latest Developments
Table 76. Novo Nordisk A/S Details, Company Type, Recombinant Coagulation Factors Area Served and Its Competitors
Table 77. Novo Nordisk A/S Recombinant Coagulation Factors Product Offered
Table 78. Novo Nordisk A/S Recombinant Coagulation Factors Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Novo Nordisk A/S Main Business
Table 80. Novo Nordisk A/S Latest Developments
Table 81. Octapharma AG Details, Company Type, Recombinant Coagulation Factors Area Served and Its Competitors
Table 82. Octapharma AG Recombinant Coagulation Factors Product Offered
Table 83. Octapharma AG Recombinant Coagulation Factors Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Octapharma AG Main Business
Table 85. Octapharma AG Latest Developments
Table 86. Pfizer Inc. Details, Company Type, Recombinant Coagulation Factors Area Served and Its Competitors
Table 87. Pfizer Inc. Recombinant Coagulation Factors Product Offered
Table 88. Pfizer Inc. Recombinant Coagulation Factors Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Pfizer Inc. Main Business
Table 90. Pfizer Inc. Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Recombinant Coagulation Factors Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Recombinant Coagulation Factors Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Recombinant Coagulation Factors Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Recombinant Coagulation Factors Sales Market Share by Country/Region (2024)
Figure 8. Recombinant Coagulation Factors Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Recombinant Coagulation Factors Market Size Market Share by Type in 2024
Figure 10. Recombinant Coagulation Factors in Hospitals
Figure 11. Global Recombinant Coagulation Factors Market: Hospitals (2020-2025) & ($ millions)
Figure 12. Recombinant Coagulation Factors in Clinics
Figure 13. Global Recombinant Coagulation Factors Market: Clinics (2020-2025) & ($ millions)
Figure 14. Recombinant Coagulation Factors in Research Organizations
Figure 15. Global Recombinant Coagulation Factors Market: Research Organizations (2020-2025) & ($ millions)
Figure 16. Global Recombinant Coagulation Factors Market Size Market Share by Application in 2024
Figure 17. Global Recombinant Coagulation Factors Revenue Market Share by Player in 2024
Figure 18. Global Recombinant Coagulation Factors Market Size Market Share by Region (2020-2025)
Figure 19. Americas Recombinant Coagulation Factors Market Size 2020-2025 ($ millions)
Figure 20. APAC Recombinant Coagulation Factors Market Size 2020-2025 ($ millions)
Figure 21. Europe Recombinant Coagulation Factors Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Recombinant Coagulation Factors Market Size 2020-2025 ($ millions)
Figure 23. Americas Recombinant Coagulation Factors Value Market Share by Country in 2024
Figure 24. United States Recombinant Coagulation Factors Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Recombinant Coagulation Factors Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Recombinant Coagulation Factors Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Recombinant Coagulation Factors Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Recombinant Coagulation Factors Market Size Market Share by Region in 2024
Figure 29. APAC Recombinant Coagulation Factors Market Size Market Share by Type (2020-2025)
Figure 30. APAC Recombinant Coagulation Factors Market Size Market Share by Application (2020-2025)
Figure 31. China Recombinant Coagulation Factors Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Recombinant Coagulation Factors Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Recombinant Coagulation Factors Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Recombinant Coagulation Factors Market Size Growth 2020-2025 ($ millions)
Figure 35. India Recombinant Coagulation Factors Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Recombinant Coagulation Factors Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Recombinant Coagulation Factors Market Size Market Share by Country in 2024
Figure 38. Europe Recombinant Coagulation Factors Market Size Market Share by Type (2020-2025)
Figure 39. Europe Recombinant Coagulation Factors Market Size Market Share by Application (2020-2025)
Figure 40. Germany Recombinant Coagulation Factors Market Size Growth 2020-2025 ($ millions)
Figure 41. France Recombinant Coagulation Factors Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Recombinant Coagulation Factors Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Recombinant Coagulation Factors Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Recombinant Coagulation Factors Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Recombinant Coagulation Factors Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Recombinant Coagulation Factors Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Recombinant Coagulation Factors Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Recombinant Coagulation Factors Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Recombinant Coagulation Factors Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Recombinant Coagulation Factors Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Recombinant Coagulation Factors Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Recombinant Coagulation Factors Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Recombinant Coagulation Factors Market Size 2026-2031 ($ millions)
Figure 54. APAC Recombinant Coagulation Factors Market Size 2026-2031 ($ millions)
Figure 55. Europe Recombinant Coagulation Factors Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Recombinant Coagulation Factors Market Size 2026-2031 ($ millions)
Figure 57. United States Recombinant Coagulation Factors Market Size 2026-2031 ($ millions)
Figure 58. Canada Recombinant Coagulation Factors Market Size 2026-2031 ($ millions)
Figure 59. Mexico Recombinant Coagulation Factors Market Size 2026-2031 ($ millions)
Figure 60. Brazil Recombinant Coagulation Factors Market Size 2026-2031 ($ millions)
Figure 61. China Recombinant Coagulation Factors Market Size 2026-2031 ($ millions)
Figure 62. Japan Recombinant Coagulation Factors Market Size 2026-2031 ($ millions)
Figure 63. Korea Recombinant Coagulation Factors Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Recombinant Coagulation Factors Market Size 2026-2031 ($ millions)
Figure 65. India Recombinant Coagulation Factors Market Size 2026-2031 ($ millions)
Figure 66. Australia Recombinant Coagulation Factors Market Size 2026-2031 ($ millions)
Figure 67. Germany Recombinant Coagulation Factors Market Size 2026-2031 ($ millions)
Figure 68. France Recombinant Coagulation Factors Market Size 2026-2031 ($ millions)
Figure 69. UK Recombinant Coagulation Factors Market Size 2026-2031 ($ millions)
Figure 70. Italy Recombinant Coagulation Factors Market Size 2026-2031 ($ millions)
Figure 71. Russia Recombinant Coagulation Factors Market Size 2026-2031 ($ millions)
Figure 72. Egypt Recombinant Coagulation Factors Market Size 2026-2031 ($ millions)
Figure 73. South Africa Recombinant Coagulation Factors Market Size 2026-2031 ($ millions)
Figure 74. Israel Recombinant Coagulation Factors Market Size 2026-2031 ($ millions)
Figure 75. Turkey Recombinant Coagulation Factors Market Size 2026-2031 ($ millions)
Figure 76. Global Recombinant Coagulation Factors Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Recombinant Coagulation Factors Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Recombinant Coagulation Factors Market Size 2026-2031 ($ millions)